[
    {
        "releaseTime": "Apr-16-23 05:30AM",
        "title": "Better Growth Stock: Axsome vs. CRISPR Therapeutics",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/200e7f85-bc4d-390c-8c34-b0c36280008b/better-growth-stock%3A-axsome.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-14-23 06:00PM",
        "title": "CRISPR Therapeutics AG (CRSP) Dips More Than Broader Markets: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-dips-220010720.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-14-23 12:49PM",
        "title": "Regulus (RGLS) Surges on Enrollment Completion for RGLS8429",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/regulus-rgls-surges-enrollment-completion-164904166.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-14-23 10:23AM",
        "title": "Is CRISPR Therapeutics Stock a Buy Now?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/ddc0ae63-843d-37e1-b75f-269be5cfbecf/is-crispr-therapeutics-stock.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-14-23 09:40AM",
        "title": "Is BioRad Laboratories (BIO) Stock Outpacing Its Medical Peers This Year?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/biorad-laboratories-bio-stock-outpacing-134001733.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-14-23 03:13AM",
        "title": "CRISPR Therapeutics AG (CRSP) Soars 16.3%: Is Further Upside Left in the Stock?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-soars-071307912.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-13-23 04:01PM",
        "title": "CRISPR Therapeutics to Participate in Needhams 22nd Annual Healthcare Conference",
        "publisher": " GlobeNewswire +16.31%",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-participate-needham-22nd-200100190.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-13-23 03:53PM",
        "title": "Crispr Therapeutics stock jumps following analyst upgrade from Cantor Fitzgerald",
        "publisher": " Yahoo Finance Video",
        "webUrl": "https://finance.yahoo.com/video/crispr-therapeutics-stock-jumps-following-195353330.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-13-23 11:58AM",
        "title": "Why Shares of CRISPR Therapeutics Jumped Thursday",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/b17e4710-8d14-3557-8806-c035aa8d3348/why-shares-of-crispr.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-13-23 10:15AM",
        "title": "2 Nasdaq Growth Stocks That Are Screaming Buys in April",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/3bad3859-e3fb-3462-8aff-feb9fc168537/2-nasdaq-growth-stocks-that.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-13-23 05:30AM",
        "title": "These Up-and-Coming Stocks Are Screaming Buys Right Now",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/d4424176-cd5e-35d1-a3ba-f8fab3f3c835/these-up-and-coming-stocks.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-12-23 06:10PM",
        "title": "UPDATE 1-Vertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/1-vertex-crisprs-gene-editing-221058308.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-12-23 05:31PM",
        "title": "Vertex/CRISPR's gene editing therapy cost effective at $1.9 million - pricing review group",
        "publisher": " Reuters",
        "webUrl": "https://finance.yahoo.com/news/vertex-crisprs-gene-editing-therapy-213109534.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-12-23 09:55AM",
        "title": "Wall Street Analysts Think CRISPR Therapeutics AG (CRSP) Could Surge 105.26%: Read This Before Placing a Bet",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/wall-street-analysts-think-crispr-135501194.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-12-23 05:30AM",
        "title": "Could This Move Make Vertex's Next Blockbuster Even Bigger?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/3f4d95b3-4587-352c-9f9f-def4f72392a6/could-this-move-make-vertex%27s.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-09-23 07:45AM",
        "title": "Where Will CRISPR Therapeutics Be in 5 Years?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/129ca92a-cc00-39f8-8fac-919e462e263f/where-will-crispr.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-08-23 05:30AM",
        "title": "CRISPR Stock: Bull vs. Bear",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/580bab95-8940-3ef6-95c0-dd74c9be09bd/crispr-stock%3A-bull-vs.-bear.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-06-23 12:19PM",
        "title": "MorphoSys Up on Finishing Early Enrolment in Myelofibrosis Study",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/morphosys-finishing-early-enrolment-myelofibrosis-161904521.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-06-23 10:23AM",
        "title": "Here's Why You Should Add Ligand (LGND) Stock to Your Portfolio",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/heres-why-add-ligand-lgnd-142302905.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-06-23 08:00AM",
        "title": "What's the Better Dip to Buy: CRISPR Therapeutics vs. Bluebird Bio",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/63ed8a28-18c6-36d4-87cf-0e555cefd738/what%27s-the-better-dip-to-buy%3A.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-05-23 12:25PM",
        "title": "AstraZeneca's (AZN) Drug Combo Meets Ovarian Cancer Study Goal",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/astrazenecas-azn-drug-combo-meets-162504788.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-05-23 11:42AM",
        "title": "VBI Vaccines (VBIV) Down 53% on Initiating Restructuring Plans",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/vbi-vaccines-vbiv-down-53-154203650.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-05-23 10:11AM",
        "title": "2 Under-the-Radar Biotech Stocks to Buy in 2023",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/0861f394-8d9c-3d30-bcc4-ba2f2adb27cb/2-under-the-radar-biotech.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-04-23 02:00PM",
        "title": "Vertex Is 1 Step Closer to Bringing a New Blockbuster to Market. Time to Buy?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/cd161530-68ba-3535-a336-2aaaf5775b79/vertex-is-1-step-closer-to.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-04-23 01:32PM",
        "title": "CRISPR (CRSP) & Vertex Complete BLA Submission for Exa-Cel",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-crsp-vertex-complete-bla-173205520.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-04-23 12:43PM",
        "title": "Ascendis (ASND) Down on Hypoparathyroidism Drug NDA Deficiencies",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/ascendis-asnd-down-hypoparathyroidism-drug-164304067.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-03-23 06:15PM",
        "title": "CRISPR Therapeutics AG (CRSP) Gains But Lags Market: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-gains-221510682.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-03-23 08:57AM",
        "title": "Emergent Biosciences (EBS) Surges 28% in a Week: Here's Why",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/emergent-biosciences-ebs-surges-28-125712309.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-03-23 08:00AM",
        "title": "Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia",
        "publisher": " Business Wire",
        "webUrl": "https://finance.yahoo.com/news/vertex-crispr-therapeutics-complete-submission-120000960.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Apr-01-23 05:30AM",
        "title": "Here's a New Million-Dollar Reason to Buy CRISPR Therapeutics",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/aa88a08e-8ec6-3811-8c3b-a5af3596a3c1/here%27s-a-new-million-dollar.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-31-23 09:00AM",
        "title": "This Top Growth Stock Is Targeting a Multi-Billion-Dollar Market. Here's What It Means for Investors",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/9040aa6a-9bf6-3fba-bcf3-ebf27dba207c/this-top-growth-stock-is.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-31-23 05:30AM",
        "title": "5 Bargain-Basement Stocks to Buy Right Now",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/4c828b33-b502-3f2a-b788-41a08e7d2931/5-bargain-basement-stocks-to.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-30-23 08:45AM",
        "title": "2 Reasons to Sell Editas Medicine Stock and 1 Reason to Buy It",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/09493797-03b3-3950-b782-8d0457c304a2/2-reasons-to-sell-editas.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-29-23 10:23PM",
        "title": "The 3 Best Growth Stocks to Buy in the Biotech Sector",
        "publisher": " InvestorPlace",
        "webUrl": "https://finance.yahoo.com/news/3-best-growth-stocks-buy-022348447.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-29-23 08:54PM",
        "title": "7 Biotech Stocks to Buy for Breakthrough Treatments and Cures",
        "publisher": " InvestorPlace",
        "webUrl": "https://finance.yahoo.com/news/7-biotech-stocks-buy-breakthrough-005448983.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-29-23 04:40PM",
        "title": "12 Most Promising Healthcare Stocks According to Analysts",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/12-most-promising-healthcare-stocks-204054903.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-29-23 04:20PM",
        "title": "11 Most Promising Gene Editing Stocks According to Analysts",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/11-most-promising-gene-editing-202010308.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-29-23 12:01PM",
        "title": "Biomea (BMEA) Up 99% on Upbeat Data From Type II Diabetes Study",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/biomea-bmea-99-upbeat-data-160104500.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-29-23 09:40AM",
        "title": "Is CRISPR Therapeutics (CRSP) Stock Outpacing Its Medical Peers This Year?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-crsp-stock-outpacing-134001363.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-29-23 08:00AM",
        "title": "CRISPR Therapeutics Announces Departure of Board Member",
        "publisher": " GlobeNewswire",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-announces-departure-board-120000289.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-28-23 11:04AM",
        "title": "Amicus (FOLD) Gets Pompe Disease Treatment Approval in Europe",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/amicus-fold-gets-pompe-disease-150403877.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-28-23 10:41AM",
        "title": "Vertex (VRTX) Inks Licensing Deal With CRISPR for Diabetes Drug",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/vertex-vrtx-inks-licensing-deal-144102283.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-27-23 12:27PM",
        "title": "Incyte's (INCY) Pemazyre Gets Approval to Treat MLNs in Japan",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/incytes-incy-pemazyre-gets-approval-162704209.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-27-23 08:00AM",
        "title": "Vertex and CRISPR Therapeutics Announce Licensing Agreement to Accelerate Development of Vertexs Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes",
        "publisher": " Business Wire",
        "webUrl": "https://finance.yahoo.com/news/vertex-crispr-therapeutics-announce-licensing-120000512.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-27-23 06:00AM",
        "title": "Could CRISPR Therapeutics Become the Next Moderna?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/55dc9f77-eb15-3922-8063-c28cd57b20d9/could-crispr-therapeutics.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-25-23 09:53AM",
        "title": "CRISPR Therapeutics AG's (NASDAQ:CRSP) latest 5.1% decline adds to one-year losses, institutional investors may consider drastic measures",
        "publisher": " Simply Wall St.",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ags-nasdaq-crsp-135329909.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-25-23 09:30AM",
        "title": "Could This Stock Become the Tesla of Its Industry?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/8fe86b45-f8d6-3ee5-a9bc-555ee418ac25/could-this-stock-become-the.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-25-23 09:17AM",
        "title": "The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket",
        "publisher": " InvestorPlace",
        "webUrl": "https://finance.yahoo.com/news/3-best-crispr-stocks-buy-131725442.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-24-23 03:02PM",
        "title": "Moderna (MRNA) Inks Genetic Medicines Deal With Generation Bio",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/moderna-mrna-inks-genetic-medicines-190207047.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-23-23 11:30AM",
        "title": "CRISPR Therapeutics AG (CRSP) Down 13.6% Since Last Earnings Report: Can It Rebound?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-down-153003144.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-23-23 11:09AM",
        "title": "Biohaven (BHVN) Acquires Dual Inhibitor for Brain Disorders",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/biohaven-bhvn-acquires-dual-inhibitor-150903276.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-23-23 10:07AM",
        "title": "This Cathie Wood Stock Could Nearly Double, According to Wall Street",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/9497dfa1-eccb-3f19-b7ac-ddf151b06b68/this-cathie-wood-stock-could.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-22-23 08:34AM",
        "title": "Intellia's (NTLA) HAE Therapy Granted RMAT by the FDA",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/intellias-ntla-hae-therapy-granted-123412208.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-22-23 07:37AM",
        "title": "Zacks Industry Outlook Highlights CRISPR Therapeutics, Ligand Pharmaceuticals, Theseus Pharmaceuticals and Kala Pharmaceuticals",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/zacks-industry-outlook-highlights-crispr-113711703.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-21-23 06:00PM",
        "title": "CRISPR Therapeutics AG (CRSP) Outpaces Stock Market Gains: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-outpaces-220010490.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-21-23 11:59AM",
        "title": "Here's Why You Should Add CRISPR Stock to Your Portfolio",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/heres-why-add-crispr-stock-155903408.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-18-23 07:18PM",
        "title": "3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time",
        "publisher": " InvestorPlace",
        "webUrl": "https://finance.yahoo.com/news/3-cutting-edge-healthcare-stocks-231856148.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-18-23 06:14AM",
        "title": "3 Beaten-Down Stocks That Could Soar This Year",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/17e240c9-9a37-332e-965b-f26c9a302cfd/3-beaten-down-stocks-that.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-16-23 11:41AM",
        "title": "Bellicum (BLCM) Down on Ending Development of CAR-T Candidates",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/bellicum-blcm-down-ending-development-154103532.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-15-23 06:00PM",
        "title": "CRISPR Therapeutics AG (CRSP) Stock Moves -0.51%: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-stock-220010719.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-15-23 10:39AM",
        "title": "Novo Nordisk (NVO) Follows Lilly, to Cut Insulin Prices by 75%",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/novo-nordisk-nvo-follows-lilly-143902101.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-15-23 10:22AM",
        "title": "AstraZeneca (AZN) Stock Up 5% in a Year: What Awaits in 2023?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/astrazeneca-azn-stock-5-awaits-142202585.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-15-23 05:30AM",
        "title": "2 Top Biotech Stocks to Buy for the Long Haul",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/38b267a2-4bdc-3476-9cce-52ec19e0e9d6/2-top-biotech-stocks-to-buy.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-14-23 06:15PM",
        "title": "CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-stock-221510225.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-14-23 06:02PM",
        "title": "CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting",
        "publisher": " GlobeNewswire",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-present-american-association-220200160.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-13-23 04:15PM",
        "title": "CRISPR Therapeutics Announces Transition of Chief Financial Officer",
        "publisher": " GlobeNewswire +5.78%",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-announces-transition-chief-201500002.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-13-23 11:39AM",
        "title": "Pfizer (PFE) Gets FDA Nod for Migraine Nasal Spray Zavzpret",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/pfizer-pfe-gets-fda-nod-153903471.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-13-23 09:40AM",
        "title": "Is BioLife Solutions (BLFS) Stock Outpacing Its Medical Peers This Year?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/biolife-solutions-blfs-stock-outpacing-134001221.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-10-23 10:42AM",
        "title": "Neoleukin (NLTX) Up 36% on Initiating Another Restructuring Plan",
        "publisher": " Zacks -5.61%",
        "webUrl": "https://finance.yahoo.com/news/neoleukin-nltx-36-initiating-another-154203468.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-10-23 10:26AM",
        "title": "AstraZeneca (AZN) Posts Positive Data From Lung Cancer Studies",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/astrazeneca-azn-posts-positive-data-152603308.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-10-23 08:15AM",
        "title": "If You Invested $10,000 in CRISPR Therapeutics In 2020, This Is How Much You Would Have Today",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/0aef70a9-e3b6-30ff-811c-105797c249d9/if-you-invested-%2410%2C000-in.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-09-23 08:50AM",
        "title": "Missed Out on Vertex? My Best Gene-Editing Stock to Buy and Hold",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/bdf217bf-0a77-3447-b999-30dad495462a/missed-out-on-vertex%3F-my-best.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-08-23 02:00PM",
        "title": "2 Healthcare Stocks That Could Help Make You a Fortune",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/bc1c2f59-5ce0-3123-ad66-152335ec8848/2-healthcare-stocks-that.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-07-23 02:48PM",
        "title": "7 Cathie Wood Stocks for Your March Buy List",
        "publisher": " InvestorPlace",
        "webUrl": "https://finance.yahoo.com/news/7-cathie-wood-stocks-march-194857190.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-06-23 12:13PM",
        "title": "3 CRISPR Gene Editing Stocks to Consider for Ground-Floor Investing",
        "publisher": " InvestorPlace",
        "webUrl": "https://finance.yahoo.com/news/3-crispr-gene-editing-stocks-171326670.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-05-23 05:30AM",
        "title": "Better Growth Stock: Moderna vs. CRISPR Therapeutics",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/20e0b0e8-627c-312b-b4d5-e3a02caa22b0/better-growth-stock%3A-moderna.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-04-23 07:25AM",
        "title": "3 Things About CRISPR Therapeutics That Smart Investors Know",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/5a4e1d4e-756b-3716-84fa-7d892ec40998/3-things-about-crispr.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-04-23 06:14AM",
        "title": "3 Game-Changing Stocks to Buy in March",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/e4306a11-d74f-3b0d-9e18-a8277fa631a7/3-game-changing-stocks-to-buy.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Mar-03-23 09:15AM",
        "title": "2 Soaring Stocks to Buy and Hold Through 2023 and Beyond",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/be9c5479-d82d-360e-9c2b-f5f040273ece/2-soaring-stocks-to-buy-and.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-28-23 02:17PM",
        "title": "Theravance's (TBPH) Q4 Earnings and Revenues Miss Estimates",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/theravances-tbph-q4-earnings-revenues-191707147.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-27-23 08:00AM",
        "title": "CRISPR Therapeutics to Participate in the 43rd Annual Cowen Health Care Conference",
        "publisher": " GlobeNewswire",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-participate-43rd-annual-130000558.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-27-23 07:15AM",
        "title": "Here's How Much You Can Make From Investing Your Tax Return Every Year",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/c2ec1c4d-6862-3ce3-a4e5-ace9ee13b937/here%27s-how-much-you-can-make.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-26-23 06:58PM",
        "title": "Analyst Report: CRISPR Therapeutics AG",
        "publisher": " Morningstar Research",
        "webUrl": "https://finance.yahoo.com/m/1c4c012e-7545-3b4f-b087-34cc7f5fcbf8/analyst-report%3A-crispr.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-25-23 11:38AM",
        "title": "10 Most Promising Biotech Stocks According to Analysts",
        "publisher": " Insider Monkey",
        "webUrl": "https://finance.yahoo.com/news/10-most-promising-biotech-stocks-163821440.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-24-23 12:00PM",
        "title": "What Makes CRISPR Therapeutics AG (CRSP) a New Buy Stock",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/makes-crispr-therapeutics-ag-crsp-170005329.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-24-23 09:40AM",
        "title": "Has CRISPR Therapeutics (CRSP) Outpaced Other Medical Stocks This Year?",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-crsp-outpaced-other-144002746.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-22-23 04:19PM",
        "title": "Crispr Therapeutics: FDA Filing on Sickle Cell Gene Therapy Is Almost Done",
        "publisher": " Barrons.com +8.04%",
        "webUrl": "https://finance.yahoo.com/m/f6f71be9-ca39-3a9b-b7dd-776bbdcbe187/crispr-therapeutics%3A-fda.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-22-23 12:42PM",
        "title": "CRISPR (CRSP) Q4 Earnings Surpass Estimates, Sales Miss",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-crsp-q4-earnings-surpass-174205190.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-22-23 08:13AM",
        "title": "Dow Jones Futures Rise: S&P 500 Nears Key Support As Nvidia Earnings Loom; Here's What To Do Now",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/3d0bc7d2-d5c1-32eb-bb35-1bfd90f7919c/dow-jones-futures-rise%3A-s%26p.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-22-23 07:22AM",
        "title": "Dow Jones Futures: S&P 500 Nears Key Support As Nvidia Earnings Loom; Here's What To Do Now",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/3d0bc7d2-d5c1-32eb-bb35-1bfd90f7919c/dow-jones-futures%3A-s%26p-500.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-22-23 06:40AM",
        "title": "Dow Jones Futures Fall: S&P 500 Nears Key Support As Nvidia Earnings Loom; Here's What To Do Now",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/3d0bc7d2-d5c1-32eb-bb35-1bfd90f7919c/dow-jones-futures-fall%3A-s%26p.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-22-23 06:13AM",
        "title": "Dow Jones Tumbles Nearly 700 Points, S&P 500 Nears Key Support; Here's What To Do Now",
        "publisher": " Investor's Business Daily",
        "webUrl": "https://finance.yahoo.com/m/3d0bc7d2-d5c1-32eb-bb35-1bfd90f7919c/dow-jones-tumbles-nearly-700.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-22-23 06:00AM",
        "title": "Better Buy: Beam Therapeutics or Intellia Therapeutics?",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/60a4df04-f433-32fb-99af-09aa3f687614/better-buy%3A-beam-therapeutics.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-21-23 05:25PM",
        "title": "CRISPR Therapeutics AG (CRSP) Reports Q4 Loss, Misses Revenue Estimates",
        "publisher": " Zacks -8.37%",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-reports-222510698.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-21-23 04:01PM",
        "title": "CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results",
        "publisher": " GlobeNewswire",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-provides-business-reports-210100194.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-21-23 09:53AM",
        "title": "2 Bruised Growth Stocks to Buy While They're Cheap",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/d17f1696-1059-3d33-95c2-58a15cb185f4/2-bruised-growth-stocks-to.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-18-23 09:07AM",
        "title": "2 Marvelous Growth Stocks to Buy Today and Hold for 5 Years or Longer",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/688195f8-db2a-376e-8327-07c8de9ee097/2-marvelous-growth-stocks-to.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-17-23 02:00PM",
        "title": "Beat the Dow Jones With CRISPR Therapeutics Stock",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/0c9a5160-a7c6-3420-a645-fdb229cc22a4/beat-the-dow-jones-with.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-17-23 10:23AM",
        "title": "These 2 Biotech Stocks Could Soar in the Next Bull Market",
        "publisher": " Motley Fool",
        "webUrl": "https://finance.yahoo.com/m/01796173-3a5c-3a22-b42d-6614b4551b9c/these-2-biotech-stocks-could.html",
        "company": "CRSP"
    },
    {
        "releaseTime": "Feb-14-23 06:00PM",
        "title": "CRISPR Therapeutics AG (CRSP) Dips More Than Broader Markets: What You Should Know",
        "publisher": " Zacks",
        "webUrl": "https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-dips-230011637.html",
        "company": "CRSP"
    }
]